BR9704554A - Utilização de lipídios complexos como adições de estabilização para composições farmacêuticas de misturas de enzimas de digestão - Google Patents
Utilização de lipídios complexos como adições de estabilização para composições farmacêuticas de misturas de enzimas de digestãoInfo
- Publication number
- BR9704554A BR9704554A BR9704554A BR9704554A BR9704554A BR 9704554 A BR9704554 A BR 9704554A BR 9704554 A BR9704554 A BR 9704554A BR 9704554 A BR9704554 A BR 9704554A BR 9704554 A BR9704554 A BR 9704554A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- enzyme mixtures
- complex lipids
- digestion enzyme
- stabilizing additions
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 238000007792 addition Methods 0.000 title 1
- 230000029087 digestion Effects 0.000 title 1
- 150000002632 lipids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000087 stabilizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19634752 | 1996-08-28 | ||
| DE19724845A DE19724845A1 (de) | 1996-08-28 | 1997-06-12 | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9704554A true BR9704554A (pt) | 1998-09-15 |
| BR9704554B1 BR9704554B1 (pt) | 2011-12-27 |
Family
ID=26028823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9704554-3A BR9704554B1 (pt) | 1996-08-28 | 1997-08-28 | utilizaÇço de lipÍdios complexos como adiÇÕes de estabilizaÇço para composiÇÕes farmacÊuticas de misturas de enzimas de digestço, composiÇÕes farmacÊuticas soléveis em Água e kit para preparaÇço de soluÇÕes aquosas. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5993806A (pt) |
| EP (1) | EP0826375B1 (pt) |
| JP (1) | JP4593697B2 (pt) |
| CN (1) | CN1199694C (pt) |
| AR (1) | AR008807A1 (pt) |
| AT (1) | ATE284225T1 (pt) |
| AU (1) | AU722151B2 (pt) |
| BR (1) | BR9704554B1 (pt) |
| CA (1) | CA2213151C (pt) |
| CZ (1) | CZ295329B6 (pt) |
| DE (2) | DE19724845A1 (pt) |
| DK (1) | DK0826375T3 (pt) |
| EE (1) | EE04179B1 (pt) |
| ES (1) | ES2235206T3 (pt) |
| HU (1) | HUP9701437A3 (pt) |
| NO (1) | NO973940L (pt) |
| NZ (1) | NZ328616A (pt) |
| PL (1) | PL190140B1 (pt) |
| PT (1) | PT826375E (pt) |
| SK (1) | SK284639B6 (pt) |
| TR (1) | TR199700872A2 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6074689A (en) * | 1998-03-10 | 2000-06-13 | Immucell Corporation | Colonic delivery of protein or peptide compositions |
| KR100367659B1 (ko) * | 2000-05-08 | 2003-01-14 | 주식회사 바이넥스 | 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법 |
| GB0019118D0 (en) * | 2000-08-03 | 2000-09-27 | Danisco | Solid phase glycerolysis |
| CA2427537A1 (en) * | 2000-11-02 | 2002-05-10 | Cilian Ag | Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| US20030099626A1 (en) * | 2001-11-20 | 2003-05-29 | Health Education Corporation | Nutrient absorption enhancing compositions and methods |
| JP5032300B2 (ja) * | 2004-03-22 | 2012-09-26 | アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 界面活性剤を含有している、リパーゼを含有する生成物の、とりわけパンクレアチンの経口医薬組成物 |
| US7153504B2 (en) * | 2004-07-30 | 2006-12-26 | Can Technologies, Inc. | Stabilized pancreas product |
| EP1919293A4 (en) * | 2005-07-20 | 2010-11-17 | James S Brophy | MODIFICATION OF PARTICLE MORPHOLOGY TO ENHANCE THE FUNCTIONALITY OF A PRODUCT |
| EP2278002B1 (en) * | 2005-07-29 | 2017-07-12 | Abbott Laboratories GmbH | Pancreatin with reduced viral content |
| US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
| US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
| US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| US20110183050A1 (en) * | 2006-07-20 | 2011-07-28 | Brophy James S | Modification of particle morphology to improve product functionality |
| US8444967B2 (en) | 2010-07-09 | 2013-05-21 | Master Supplements, Inc. | Treatment including prebiotic composition for use with probiotics |
| US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
| DE102009006594A1 (de) | 2009-01-29 | 2010-08-05 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutisches Präparat |
| EP2391382B1 (de) | 2009-01-29 | 2014-06-04 | Nordmark Arzneimittel GmbH & Co.KG | Pharmazeutisches präparat enthaltend lipase bakteriellen ursprungs |
| CN108187033A (zh) | 2010-10-01 | 2018-06-22 | 阿普塔利斯制药有限公司 | 肠溶包衣的低强度胰脂肪酶制剂 |
| WO2015069677A1 (en) * | 2013-11-05 | 2015-05-14 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
| EP3030257B1 (en) | 2013-08-09 | 2020-02-19 | Allergan Pharmaceuticals International Limited | Digestive enzyme composition suitable for enteral administration |
| JP2014193909A (ja) * | 2014-06-04 | 2014-10-09 | Nordmark Arzneimittel Gmbh & Co Kg | 医薬調製物 |
| US20160120964A1 (en) * | 2014-11-05 | 2016-05-05 | George Shlieout | Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical use |
| US20180028454A1 (en) | 2015-02-04 | 2018-02-01 | Abbvie Inc. | Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency |
| DE102015114857A1 (de) | 2015-09-04 | 2017-03-09 | Nordmark Arzneimittel Gmbh & Co. Kg | Getränk, enthaltend eine pharmazeutische Zusammensetzung |
| DE102015114862A1 (de) * | 2015-09-04 | 2017-03-09 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3956483A (en) * | 1968-10-24 | 1976-05-11 | Wilson Pharmaceutical & Chemical Corporation | Preparing pancreatin |
| US3991180A (en) * | 1972-03-06 | 1976-11-09 | Rohm And Haas Company | Stabilization of internally administered pancreatic lipase |
| DE2512746C3 (de) * | 1975-03-22 | 1980-04-24 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin |
| GB1603640A (en) * | 1977-07-20 | 1981-11-25 | Gist Brocades Nv | Enzyme particles |
| JPS58148814A (ja) * | 1982-03-01 | 1983-09-05 | Fujimoto Seiyaku Kk | 消化酵素軟カプセル剤 |
| JPS59169491A (ja) * | 1983-03-15 | 1984-09-25 | Duskin Franchise Co Ltd | 酵素の安定化法 |
| JPH0229950A (ja) * | 1988-07-18 | 1990-01-31 | Nec Corp | 光ディスク |
| JP2679852B2 (ja) * | 1989-11-29 | 1997-11-19 | 株式会社サム研究所 | 経口及び局所投与用生物活性蛋白組成物 |
| GB9007052D0 (en) * | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
| EP1961312A3 (en) * | 1991-01-24 | 2010-03-31 | Martek Biosciences Corporation | Microbial oil mixture and uses thereof |
| DE4200002A1 (de) * | 1992-01-02 | 1993-07-08 | Rudolf V Dipl Chem Dr Noronha | Reinigungstablette fuer die zahnprothesen |
| EP0719133A1 (en) * | 1993-09-15 | 1996-07-03 | Unilever Plc | Skin care method and composition |
| JPH09125096A (ja) * | 1995-10-30 | 1997-05-13 | Koei Sangyo:Kk | 液状天然油脂洗剤 |
-
1997
- 1997-06-12 DE DE19724845A patent/DE19724845A1/de not_active Withdrawn
- 1997-07-09 CZ CZ19972184A patent/CZ295329B6/cs not_active IP Right Cessation
- 1997-08-01 AR ARP970103511A patent/AR008807A1/es unknown
- 1997-08-18 CA CA002213151A patent/CA2213151C/en not_active Expired - Fee Related
- 1997-08-20 AT AT97114330T patent/ATE284225T1/de not_active IP Right Cessation
- 1997-08-20 DE DE1997512108 patent/DE59712108D1/de not_active Expired - Lifetime
- 1997-08-20 ES ES97114330T patent/ES2235206T3/es not_active Expired - Lifetime
- 1997-08-20 PT PT97114330T patent/PT826375E/pt unknown
- 1997-08-20 DK DK97114330T patent/DK0826375T3/da active
- 1997-08-20 EP EP97114330A patent/EP0826375B1/de not_active Expired - Lifetime
- 1997-08-22 SK SK1159-97A patent/SK284639B6/sk unknown
- 1997-08-22 US US08/916,325 patent/US5993806A/en not_active Expired - Lifetime
- 1997-08-25 JP JP22800897A patent/JP4593697B2/ja not_active Expired - Lifetime
- 1997-08-25 HU HU9701437A patent/HUP9701437A3/hu unknown
- 1997-08-27 AU AU35309/97A patent/AU722151B2/en not_active Ceased
- 1997-08-27 NO NO973940A patent/NO973940L/no not_active Application Discontinuation
- 1997-08-27 PL PL97321825A patent/PL190140B1/pl unknown
- 1997-08-27 NZ NZ328616A patent/NZ328616A/xx unknown
- 1997-08-27 CN CNB971177007A patent/CN1199694C/zh not_active Expired - Fee Related
- 1997-08-28 EE EE9700249A patent/EE04179B1/xx not_active IP Right Cessation
- 1997-08-28 BR BRPI9704554-3A patent/BR9704554B1/pt not_active IP Right Cessation
- 1997-08-28 TR TR97/00872A patent/TR199700872A2/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9704554A (pt) | Utilização de lipídios complexos como adições de estabilização para composições farmacêuticas de misturas de enzimas de digestão | |
| ID24372A (id) | SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs | |
| PT998272E (pt) | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol | |
| ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
| PT1066027E (pt) | Composicao farmaceutica de topiramato | |
| ES2015535B3 (es) | Composiciones detergentes, componentes de estas, y procedimientos para su preparacion | |
| BR9708735A (pt) | Derivados de uréia como inibidores da enzina impdh | |
| ID29994A (id) | Komposisi farmasi untuk melawan ccr5 terdiri dari turunan anilida | |
| HUP0001170A3 (en) | Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer | |
| EP1254899A3 (en) | Piperazine derivatives and their use as anti-inflammatory agents | |
| FI964583L (fi) | Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi | |
| NO20002443L (no) | FremgangsmÕte for fremstilling av derivater av taxoidklassen | |
| FI20001412L (fi) | Steroliesterit elintarvikelisäaineina | |
| PT907364E (pt) | Composicao farmaceutica de libertacao sustida | |
| EP0785772A4 (en) | LYOPHILISATE OF A LIPID COMPLEX OF WATER-INSOLUBLE CAMTOTHECINS | |
| NO990435D0 (no) | Fremstilling av estere som overflateaktive midler | |
| ATE497786T1 (de) | Zusammensetzungen und kits zur erhöhung der abgabe von therapeutischen mitteln an zellen | |
| ID29966A (id) | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi | |
| DE69927585D1 (de) | Alpha-hydroxy fettsäurenderivate und zubereitungen zur äusserlichen anwendung diese enthaltend | |
| PL332282A1 (en) | Application of proteins as factors against autoimmunological diseases | |
| PT1097159E (pt) | Utilizacao de derivados de acidos fosfinicos e fosfonicos como medicamentos | |
| MX9100886A (es) | Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen | |
| ID24694A (id) | Pemakaian bentuk zat-zat sebagai katalis untuk pembuatan kaprolaktam | |
| DE59813114D1 (de) | BK-RiV-Präparate zur Behandlung von proliferativen Zellerkrangungen | |
| ZA981729B (en) | Use of pivagabin to prepare pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB34 | Technical and formal requirements: requirement - article 34 of industrial property law | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/12/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25D | Requested change of name of applicant approved | ||
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time | ||
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |